Shanghai, China

Chenmin Tian

This inventor holds 1 USPTO granted patent and 6 published patent applications. Top assignees: Jiangsu Hengrui Medicine Company Ltd., Shanghai Hengrui Pharmaceutical. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Chenmin Tian. Retrieved from https://idiyas.com/inventor/chenmin-tian

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Chenmin Tian: Innovator in Pharmaceutical Composition

Introduction

Chenmin Tian is a notable inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceuticals, particularly with his innovative work on receptor fusion proteins. His expertise and dedication to research have led to the development of valuable medical solutions.

Latest Patents

Chenmin Tian holds a patent for a TGF-beta receptor fusion protein pharmaceutical composition and its use. This invention represents a significant advancement in therapeutic options for various medical conditions. The patent showcases his commitment to improving healthcare through innovative solutions.

Career Highlights

Throughout his career, Chenmin Tian has worked with prominent companies in the pharmaceutical industry. He has been associated with Jiangsu Hengrui Medicine Co., Ltd. and Shanghai Hengrui Pharmaceutical. His experience in these organizations has allowed him to contribute to the development of cutting-edge medical technologies.

Collaborations

Chenmin Tian has collaborated with esteemed colleagues, including Xun Liu and Tao Wang. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

In summary, Chenmin Tian is a distinguished inventor whose work in pharmaceutical compositions has made a significant impact in the field. His patent and collaborations reflect his dedication to advancing medical science and improving patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…